Infección por Delta en el Reino Unido.

Real-world management of juvenile autoimmune liver disease.

United European gastroenterology journal·2018

Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis.

Alimentary pharmacology & therapeutics·2018

Spectroscopic identification of r-process nucleosynthesis in a double neutron-star merger.

Nature·2017

Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.

Clinical and experimental immunology·2017

Pattern of Liver Disease Following High-Dose Cytosine Arabinoside (HDARAC) Therapy in Children with Acute Myeloid Leukemia.

Leukemia & lymphoma·2016

Autoimmune hepatitis: From mechanisms to therapy.

Revista clinica espanola·2016

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023.

Journal of viral hepatitis·2026

Evolving cigarette and hand-rolling tobacco purchasing patterns ahead of smokefree generation legislation in Great Britain: a population study, 2020-2025.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026

Gender Differences in the Protective Effects of Social Participation on Depressive Symptom Trajectories Among Middle-Aged and Older Adults in China: A Nationwide Longitudinal Study.

Healthcare (Basel, Switzerland)·2026

Sex differences in fetal mortality in Spain: historical trends and social and biological determinants.

Gaceta sanitaria·2026

Temporal trend and influencing factors of high-risk pregnancy in China: a nationwide longitudinal analysis.

Frontiers in public health·2026

Two universal pathways in demographic transition.

Evolutionary human sciences·2026

Videos de Experimentos Relacionados

Infección por Delta en el Reino Unido.

Videos de Conceptos Relacionados

Real-world management of juvenile autoimmune liver disease.

Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis.

Spectroscopic identification of r-process nucleosynthesis in a double neutron-star merger.

Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.

Pattern of Liver Disease Following High-Dose Cytosine Arabinoside (HDARAC) Therapy in Children with Acute Myeloid Leukemia.

Autoimmune hepatitis: From mechanisms to therapy.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023.

Evolving cigarette and hand-rolling tobacco purchasing patterns ahead of smokefree generation legislation in Great Britain: a population study, 2020-2025.

Gender Differences in the Protective Effects of Social Participation on Depressive Symptom Trajectories Among Middle-Aged and Older Adults in China: A Nationwide Longitudinal Study.

Sex differences in fetal mortality in Spain: historical trends and social and biological determinants.

Temporal trend and influencing factors of high-risk pregnancy in China: a nationwide longitudinal analysis.

Two universal pathways in demographic transition.

Videos de Experimentos Relacionados

Infección por Delta en el Reino Unido.

Videos de Conceptos Relacionados

Artículos Relacionados